Su He Wang

Publication Activity (10 Years)

Years Active: 2022-2024
Publications (10 Years): 6

Top Topics

Epidermal Growth Factor Receptor

Small Cell Lung Cancer

Top Venues

Cancer gene therapy

Microbiology spectrum

This page only lists publications with an associated author ORCID identifier.

Publications

Su He Wang, Zhengyi Cao, Mohammad Farazuddin, Jesse Chen, Katarzyna W Janczak, Shengzhuang Tang, Jayme Cannon, James R Baker
A novel intranasal peptide vaccine inhibits non-small cell lung cancer with KRAS mutation. Cancer gene therapy 31 (3) (2024)
Su He Wang, Zhengyi Cao, Mohammad Farazuddin, Jesse Chen, Katarzyna W Janczak, Shengzhuang Tang, Jayme Cannon, James R Baker
A novel intranasal peptide vaccine inhibits non-small cell lung cancer with KRAS mutation. Cancer gene therapy 31 (3) (2024)
Su He Wang, Zhengyi Cao, Mohammad Farazuddin, Jesse Chen, Katarzyna W Janczak, Shengzhuang Tang, Jayme Cannon, James R Baker
A novel intranasal peptide vaccine inhibits non-small cell lung cancer with KRAS mutation. Cancer gene therapy 31 (3) (2024)
Su He Wang, Zhengyi Cao, Mohammad Farazuddin, Jesse Chen, Katarzyna W Janczak, Shengzhuang Tang, Jayme Cannon, James R Baker
A novel intranasal peptide vaccine inhibits non-small cell lung cancer with KRAS mutation. Cancer gene therapy (2024)
Shengzhuang Tang, Jesse Chen, Jayme Cannon, Mona Chekuri, Mohammad Farazuddin, James R Baker, Su He Wang
Delicate Hybrid Laponite-Cyclic Poly(ethylene glycol) Nanoparticles as a Potential Drug Delivery System. Pharmaceutics 15 (7) (2023)
Jesse Chen, Zhengyi Cao, Jayme Cannon, Yongyi Fan, James R Baker, Su He Wang
Effective Treatment of Skin Wounds Co-Infected with Multidrug-Resistant Bacteria with a Novel Nanoemulsion. Microbiology spectrum 10 (2) (2022)